AmySwiftMD
Psychiatry • New York, NYAddiction
Medical Director, Addiction Psychiatry Program Director, Addiction Psychiatry Fellowship
Dr. Swift is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Nathan D Perlman Pl
Bernstein Building 6th Fl
New York, NY 10003Phone+1 212-240-2466
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Addiction Psychiatry, 2016 - 2017- Icahn School of Medicine at Mount Sinai (Beth Israel)Chief Residency, Psychiatry, 2015 - 2016
- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2012 - 2016
New York Medical CollegeClass of 2012
Certifications & Licensure
CT State Medical License 2024 - 2025
NY State Medical License 2013 - 2025- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Addiction Psychiatry
Publications & Presentations
PubMed
- 3 citationsCannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis.Anahita Bassir Nia, Claire L Gibson, Sharron A Spriggs, Samantha E Jankowski, Daniel DeFrancisco
Journal of Psychopharmacology. 2023-05-01 - 10 citationsCannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.Claire L. Gibson, Anahita Bassir Nia, Sharron Spriggs, Daniel DeFrancisco, Amy Swift
Psychiatry Research. 2020-11-01
Press Mentions
Prescribing Benzodiazepines as-Needed Leads to AbuseDecember 26th, 2016
The AMA Does Not Speak for UsDecember 9th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
